ΒιΆΉ΄«Γ½

Meeting Coverage

CTAD

Clinical Trials on Alzheimer's Disease Conference

Targeted Magnetic Stimulation Slows Alzheimer's Progression in Phase II Study

Neuro-navigated repetitive TMS in the precuneus slowed progression in mild-to-moderate disease

image

Latest CTAD Meeting Coverage

Alzheimer's Diagnosis Takes More Than Biomarkers, Working Group Says

Competing definition that includes cognitive symptoms proposed

November 4, 2024
Alzheimer's Progression May Be Slowed by Targeted Magnetic Pulses, Study Suggests

In phase II trial, transcranial stimulation led to significant differences versus placebo

November 3, 2024
Omega-3 Supplements Show Benefit in APOE4 Carriers

Trial finds DHA can penetrate the brain before dementia onset

November 1, 2024
Leukemia Drug Shows Promise in Dementia With Lewy Bodies

Cognitive outcomes, biomarkers improved with nilotinib in phase II trial

October 30, 2024
Brain Edema Risk May Be Lower With Modified Donanemab Dosing

Different regimen showed comparable pharmacokinetic and pharmacodynamic results

October 29, 2024

Latest Neurology Meeting Coverage